Literature DB >> 16299682

Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients.

Sema Uslu1, Belgin Efe, Ozkan Alataş, Nur Kebapçi, Omer Colak, Canan Demirüstü, Ayşe Yörük.   

Abstract

BACKGROUND: In clinical practice, the assessment and follow-up of early renal dysfunction is important in diabetic nephropathy. Therefore, this study was designed to determine whether the serum cystatin C (Cys C) and activities of some tubular enzymes could be used as screening markers for renal dysfunction in diabetic patients.
METHODS: Serum Cys C levels and urinary activities of N-acetyl-b-D-glucosaminidase (NAG), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) and whole blood glycolyse hemoglobin (HbA1C) were measured in 56 diabetic patients and 20 healthy subjects (controls). The results were compared with serum creatinine (Cr) and creatinine clearance (CCr), which were measured and estimated with the Cockcroft-Gault formula (CCG) and 24-hr urine microalbuminuria (MAU). We examined the influence of albuminuria, HbA1C and CCr levels of patients on the levels of the analyzed parameters. Sensitivity and specificity for the diagnosis of renal impairment were calculated by a receiver operating characteristics (ROC) curve for serum Cys C, Cr and urinary enzymes.
RESULTS: In normoalbuminurics, only serum Cys C levels and urinary NAG activities were found elevated as compared to controls. In addition to the elevation of serum Cys C levels and urinary activities of NAG, urinary ALP and LDH activities were also found elevated in microalbuminurics. Serum Cys C levels and urinary NAG, ALP, LDH activities started to increase above the normal range when CCr declined and while serum Cr was in the normal range in patients with 50<CCr<80 (grade 2 group). Moreover, these parameters in patients with good metabolic control were significantly lower than in patients with poor metabolic control. There was a significant positive correlation between serum Cys C, urinary NAG, LDH, ALP activities and serum Cr levels. However, there was an inverse correlation between serum Cys C, urinary NAG, LDH, ALP and CCr and CCG in diabetic patients. The ROC plot indicated that serum Cys C and urinary NAG and ALP had higher sensitivity than serum Cr and met the criteria for detecting glomerular and tubular dysfunction as screening tests for early diagnosis of diabetic nephropathy.
CONCLUSION: This study demonstrated that measuring serum Cys C levels and urinary NAG, ALP and LDH activities could be useful as screening markers to follow-up glomerular and tubular dysfunction in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299682

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  22 in total

1.  Serum cystatin-C evaluation in dogs affected by different diseases associated or not with renal insufficiency.

Authors:  M T Antognoni; D Siepi; F Porciello; F Rueca; G Fruganti
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

2.  Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.

Authors:  Suijun Wang; Yanfang Wang; Ruizhi Zheng; Zhigang Zhao; Yuehua Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 3.  Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease.

Authors:  Helen C Looker; Michael Mauer; Robert G Nelson
Journal:  Adv Chronic Kidney Dis       Date:  2018-03       Impact factor: 3.620

4.  Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.

Authors:  Kevin Damman; Dirk J Van Veldhuisen; Gerjan Navis; Vishal S Vaidya; Tom D J Smilde; B Daan Westenbrink; Joseph V Bonventre; Adriaan A Voors; Hans L Hillege
Journal:  Heart       Date:  2010-08       Impact factor: 5.994

Review 5.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25

6.  Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.

Authors:  E Santini; S Madec; V Corretti; E Ferrannini; A Solini
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

7.  Determination of urinary enzymes as a marker of early renal damage in diabetic patients.

Authors:  Ali Mohammadi-Karakani; Solmaz Asgharzadeh-Haghighi; Mahmoud Ghazi-Khansari; Rohollah Hosseini
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 8.  Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.

Authors:  Petter Bjornstad; David Z Cherney; David M Maahs; Kristen J Nadeau
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

9.  Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial.

Authors:  Ligia Petrica; Maxim Petrica; Adrian Vlad; Catalin Dragos Jianu; Gheorghe Gluhovschi; Calina Ianculescu; Victor Dumitrascu; Sorin Giju; Cristina Gluhovschi; Flaviu Bob; Sorin Ursoniu; Florica Gadalean; Silvia Velciov; Gheorghe Bozdog; Roxana Marian
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

10.  Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative.

Authors:  Claudio Ronco; Peter McCullough; Stefan D Anker; Inder Anand; Nadia Aspromonte; Sean M Bagshaw; Rinaldo Bellomo; Tomas Berl; Ilona Bobek; Dinna N Cruz; Luciano Daliento; Andrew Davenport; Mikko Haapio; Hans Hillege; Andrew A House; Nevin Katz; Alan Maisel; Sunil Mankad; Pierluigi Zanco; Alexandre Mebazaa; Alberto Palazzuoli; Federico Ronco; Andrew Shaw; Geoff Sheinfeld; Sachin Soni; Giorgio Vescovo; Nereo Zamperetti; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2009-12-25       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.